Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pancreatitis, Acute Necrotizing | 4 | 2023 | 172 | 1.790 |
Why?
|
Wounds, Penetrating | 4 | 2022 | 306 | 1.190 |
Why?
|
Artificial Intelligence | 9 | 2023 | 2124 | 1.080 |
Why?
|
Pelvic Bones | 2 | 2023 | 264 | 0.940 |
Why?
|
Wounds, Nonpenetrating | 4 | 2022 | 788 | 0.890 |
Why?
|
Salts | 1 | 2020 | 65 | 0.730 |
Why?
|
Emergency Treatment | 2 | 2021 | 516 | 0.730 |
Why?
|
Diverticulitis | 1 | 2021 | 169 | 0.680 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2020 | 224 | 0.670 |
Why?
|
Gallstones | 1 | 2020 | 286 | 0.630 |
Why?
|
General Surgery | 4 | 2022 | 1630 | 0.630 |
Why?
|
Language | 2 | 2022 | 1447 | 0.530 |
Why?
|
Catheterization | 1 | 2020 | 1466 | 0.510 |
Why?
|
Fractures, Bone | 2 | 2023 | 1939 | 0.470 |
Why?
|
Heparin | 1 | 2020 | 1637 | 0.450 |
Why?
|
Surgical Procedures, Operative | 2 | 2021 | 1867 | 0.430 |
Why?
|
Hospital Mortality | 11 | 2022 | 5305 | 0.430 |
Why?
|
Decision Support Systems, Clinical | 1 | 2020 | 1162 | 0.390 |
Why?
|
Decision Support Techniques | 1 | 2021 | 1957 | 0.390 |
Why?
|
Critical Illness | 7 | 2021 | 2656 | 0.370 |
Why?
|
Postoperative Complications | 8 | 2023 | 15194 | 0.360 |
Why?
|
Gastrointestinal Diseases | 4 | 2021 | 1162 | 0.350 |
Why?
|
Debridement | 2 | 2023 | 491 | 0.330 |
Why?
|
Colonic Neoplasms | 1 | 2020 | 2530 | 0.330 |
Why?
|
Databases, Factual | 7 | 2023 | 7690 | 0.320 |
Why?
|
Opioid-Related Disorders | 1 | 2023 | 2059 | 0.310 |
Why?
|
Drainage | 3 | 2023 | 1139 | 0.300 |
Why?
|
Trauma Centers | 5 | 2022 | 888 | 0.290 |
Why?
|
Morphine Derivatives | 2 | 2023 | 44 | 0.280 |
Why?
|
Wounds and Injuries | 3 | 2022 | 2394 | 0.260 |
Why?
|
Quality Improvement | 1 | 2020 | 3730 | 0.250 |
Why?
|
Intensive Care Units | 6 | 2022 | 3672 | 0.230 |
Why?
|
Retrospective Studies | 17 | 2023 | 76631 | 0.220 |
Why?
|
Physicians | 1 | 2020 | 4539 | 0.210 |
Why?
|
Cuba | 1 | 2021 | 47 | 0.200 |
Why?
|
Endoscopy | 2 | 2023 | 1762 | 0.200 |
Why?
|
Central America | 1 | 2021 | 68 | 0.200 |
Why?
|
Hemorrhage | 3 | 2023 | 3441 | 0.200 |
Why?
|
Injury Severity Score | 2 | 2021 | 1011 | 0.200 |
Why?
|
Medical Futility | 1 | 2022 | 126 | 0.200 |
Why?
|
Subacute Care | 1 | 2023 | 168 | 0.200 |
Why?
|
Appendectomy | 2 | 2022 | 398 | 0.190 |
Why?
|
South America | 1 | 2021 | 181 | 0.190 |
Why?
|
Indiana | 1 | 2020 | 92 | 0.190 |
Why?
|
New Jersey | 1 | 2021 | 289 | 0.190 |
Why?
|
Benchmarking | 3 | 2023 | 1034 | 0.190 |
Why?
|
Humans | 41 | 2023 | 739398 | 0.190 |
Why?
|
Puerto Rico | 1 | 2021 | 354 | 0.180 |
Why?
|
Cholecystectomy | 1 | 2022 | 387 | 0.180 |
Why?
|
Rhabdomyolysis | 1 | 2021 | 150 | 0.180 |
Why?
|
Communication Barriers | 1 | 2022 | 399 | 0.170 |
Why?
|
Length of Stay | 6 | 2022 | 6295 | 0.170 |
Why?
|
Mexico | 1 | 2021 | 683 | 0.170 |
Why?
|
Laparotomy | 1 | 2021 | 472 | 0.160 |
Why?
|
Computers, Handheld | 1 | 2020 | 210 | 0.160 |
Why?
|
Necrosis | 1 | 2023 | 1643 | 0.160 |
Why?
|
Ethiopia | 1 | 2020 | 490 | 0.160 |
Why?
|
Aged | 16 | 2023 | 162698 | 0.160 |
Why?
|
Female | 23 | 2023 | 378853 | 0.160 |
Why?
|
Patient Readmission | 2 | 2022 | 3106 | 0.150 |
Why?
|
Adult | 15 | 2023 | 213394 | 0.150 |
Why?
|
Male | 21 | 2023 | 349022 | 0.150 |
Why?
|
Middle Aged | 17 | 2022 | 212863 | 0.150 |
Why?
|
Critical Care | 4 | 2022 | 2624 | 0.150 |
Why?
|
Aftercare | 1 | 2023 | 858 | 0.140 |
Why?
|
Risk Assessment | 7 | 2023 | 23294 | 0.140 |
Why?
|
Analgesics, Opioid | 2 | 2023 | 3650 | 0.140 |
Why?
|
Colectomy | 1 | 2021 | 681 | 0.140 |
Why?
|
Pandemics | 5 | 2022 | 8274 | 0.140 |
Why?
|
Hernia | 1 | 2016 | 71 | 0.140 |
Why?
|
Pain, Postoperative | 2 | 2023 | 1638 | 0.130 |
Why?
|
Respiratory Insufficiency | 1 | 2023 | 1197 | 0.130 |
Why?
|
Emergencies | 1 | 2021 | 1152 | 0.130 |
Why?
|
Hypotension | 1 | 2020 | 881 | 0.120 |
Why?
|
Risk Factors | 7 | 2021 | 71974 | 0.120 |
Why?
|
Postoperative Care | 1 | 2020 | 1477 | 0.120 |
Why?
|
Massachusetts | 3 | 2021 | 8669 | 0.120 |
Why?
|
Axons | 2 | 2010 | 1689 | 0.110 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3143 | 0.110 |
Why?
|
Embolization, Therapeutic | 1 | 2022 | 1376 | 0.110 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3248 | 0.100 |
Why?
|
Emergency Medical Services | 1 | 2023 | 1904 | 0.100 |
Why?
|
Acute Kidney Injury | 2 | 2021 | 1941 | 0.100 |
Why?
|
Fasciculation | 1 | 2010 | 8 | 0.100 |
Why?
|
Cyclic Nucleotide-Gated Cation Channels | 1 | 2010 | 37 | 0.100 |
Why?
|
Olfactory Nerve | 1 | 2010 | 22 | 0.100 |
Why?
|
Multivariate Analysis | 2 | 2021 | 12237 | 0.090 |
Why?
|
Obesity, Morbid | 1 | 2021 | 1191 | 0.090 |
Why?
|
Prone Position | 2 | 2021 | 194 | 0.090 |
Why?
|
Patient Discharge | 1 | 2023 | 3286 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1673 | 0.090 |
Why?
|
Olfactory Receptor Neurons | 1 | 2010 | 92 | 0.090 |
Why?
|
Pulmonary Embolism | 1 | 2022 | 2365 | 0.090 |
Why?
|
Treatment Outcome | 5 | 2023 | 62693 | 0.090 |
Why?
|
Appendicitis | 1 | 2016 | 639 | 0.090 |
Why?
|
Creatine Kinase | 2 | 2021 | 694 | 0.080 |
Why?
|
Cohort Studies | 5 | 2023 | 40389 | 0.080 |
Why?
|
Potassium Channels | 1 | 2010 | 563 | 0.080 |
Why?
|
Decision Making | 1 | 2021 | 3854 | 0.070 |
Why?
|
Cesarean Section | 1 | 2016 | 1371 | 0.070 |
Why?
|
Comorbidity | 4 | 2021 | 10362 | 0.070 |
Why?
|
Thrombosis | 1 | 2020 | 2961 | 0.070 |
Why?
|
Sensory Receptor Cells | 1 | 2010 | 475 | 0.070 |
Why?
|
Medicare | 1 | 2023 | 6497 | 0.070 |
Why?
|
Blood Transfusion | 2 | 2022 | 1296 | 0.070 |
Why?
|
Substance-Related Disorders | 1 | 2021 | 4239 | 0.070 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15036 | 0.060 |
Why?
|
Blood Pressure | 1 | 2020 | 8554 | 0.060 |
Why?
|
Hospitalization | 2 | 2021 | 10208 | 0.060 |
Why?
|
Neurogenesis | 1 | 2010 | 821 | 0.060 |
Why?
|
United States | 5 | 2023 | 69573 | 0.060 |
Why?
|
Telemedicine | 1 | 2020 | 2844 | 0.060 |
Why?
|
Hemoperitoneum | 1 | 2022 | 40 | 0.050 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2010 | 3615 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5272 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2021 | 57650 | 0.050 |
Why?
|
Receptors, Odorant | 2 | 2010 | 59 | 0.050 |
Why?
|
Neural Cell Adhesion Molecules | 2 | 2010 | 126 | 0.050 |
Why?
|
Neuromuscular Blockade | 1 | 2021 | 146 | 0.040 |
Why?
|
Algorithms | 1 | 2020 | 13872 | 0.040 |
Why?
|
Pressure Ulcer | 1 | 2021 | 154 | 0.040 |
Why?
|
Decision Trees | 1 | 2021 | 507 | 0.040 |
Why?
|
Shock | 1 | 2021 | 318 | 0.040 |
Why?
|
Kidney Function Tests | 1 | 2020 | 681 | 0.040 |
Why?
|
Pneumonia, Bacterial | 1 | 2021 | 316 | 0.040 |
Why?
|
Emergency Service, Hospital | 3 | 2022 | 7626 | 0.040 |
Why?
|
Boston | 2 | 2021 | 9314 | 0.040 |
Why?
|
Resuscitation | 1 | 2022 | 656 | 0.040 |
Why?
|
Hydroxychloroquine | 1 | 2021 | 407 | 0.040 |
Why?
|
Diffusion of Innovation | 1 | 2021 | 725 | 0.030 |
Why?
|
Hospitals, General | 1 | 2020 | 744 | 0.030 |
Why?
|
Survival Rate | 2 | 2021 | 12761 | 0.030 |
Why?
|
Steroids | 1 | 2021 | 925 | 0.030 |
Why?
|
Groin | 1 | 2016 | 102 | 0.030 |
Why?
|
Analgesics | 1 | 2022 | 1034 | 0.030 |
Why?
|
Ethanol | 1 | 2021 | 1329 | 0.030 |
Why?
|
Green Fluorescent Proteins | 2 | 2010 | 2092 | 0.030 |
Why?
|
Thromboembolism | 1 | 2021 | 984 | 0.030 |
Why?
|
Social Class | 1 | 2023 | 1974 | 0.030 |
Why?
|
ROC Curve | 1 | 2022 | 3526 | 0.030 |
Why?
|
Embryo, Mammalian | 2 | 2010 | 1698 | 0.030 |
Why?
|
Antimalarials | 1 | 2021 | 913 | 0.030 |
Why?
|
Propensity Score | 1 | 2020 | 1749 | 0.030 |
Why?
|
Surgery, Computer-Assisted | 1 | 2021 | 1008 | 0.030 |
Why?
|
Incidence | 2 | 2021 | 20913 | 0.030 |
Why?
|
Patient Admission | 1 | 2020 | 1383 | 0.030 |
Why?
|
Drug Prescriptions | 1 | 2022 | 1637 | 0.030 |
Why?
|
Prospective Studies | 3 | 2021 | 53037 | 0.030 |
Why?
|
Insurance Coverage | 1 | 2023 | 1891 | 0.030 |
Why?
|
Loperamide | 1 | 2010 | 7 | 0.020 |
Why?
|
GAP-43 Protein | 1 | 2010 | 152 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2021 | 5058 | 0.020 |
Why?
|
Antidiarrheals | 1 | 2010 | 45 | 0.020 |
Why?
|
NAD(P)H Dehydrogenase (Quinone) | 1 | 2010 | 46 | 0.020 |
Why?
|
Postoperative Period | 1 | 2016 | 1835 | 0.020 |
Why?
|
Nitrogen Oxides | 1 | 2010 | 129 | 0.020 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2021 | 1339 | 0.020 |
Why?
|
Neuropilin-1 | 1 | 2010 | 91 | 0.020 |
Why?
|
Medicaid | 1 | 2023 | 2711 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6516 | 0.020 |
Why?
|
Age Factors | 2 | 2021 | 18349 | 0.020 |
Why?
|
Disease Management | 1 | 2020 | 2448 | 0.020 |
Why?
|
Olfactory Bulb | 1 | 2010 | 203 | 0.020 |
Why?
|
Biophysics | 1 | 2010 | 384 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3916 | 0.020 |
Why?
|
Patch-Clamp Techniques | 1 | 2010 | 958 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2020 | 3609 | 0.020 |
Why?
|
Caspase 3 | 1 | 2010 | 758 | 0.020 |
Why?
|
Cardiotonic Agents | 1 | 2010 | 535 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10247 | 0.020 |
Why?
|
Membrane Potentials | 1 | 2010 | 1134 | 0.020 |
Why?
|
Mesoderm | 1 | 2010 | 683 | 0.020 |
Why?
|
Anticoagulants | 1 | 2022 | 4582 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10398 | 0.020 |
Why?
|
Ion Channels | 1 | 2010 | 1056 | 0.020 |
Why?
|
Electric Stimulation | 1 | 2010 | 1769 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2010 | 2732 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2010 | 1967 | 0.020 |
Why?
|
Prevalence | 1 | 2020 | 15153 | 0.010 |
Why?
|
Developing Countries | 1 | 2016 | 2779 | 0.010 |
Why?
|
Body Mass Index | 1 | 2021 | 12655 | 0.010 |
Why?
|
Prognosis | 1 | 2023 | 28901 | 0.010 |
Why?
|
Pregnancy | 2 | 2016 | 29002 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 24714 | 0.010 |
Why?
|
Pyrimidines | 1 | 2010 | 2918 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2010 | 9734 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2010 | 4463 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2010 | 4035 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2010 | 14558 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 56255 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2010 | 19220 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 85405 | 0.010 |
Why?
|
Mice | 2 | 2010 | 81002 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2010 | 21863 | 0.010 |
Why?
|
Animals | 2 | 2010 | 168368 | 0.010 |
Why?
|
Concepts
(195)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(41)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_